logo

For the Inventor, By the Inventor

Turku, Finland

Hormos Medical Corporation


USPTO Granted Patents = 22

% Expired Patents = 40.9



Forward Citations = 34

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Risto Santti (6 out of 12 patents)

silverMedal Tomi Streng (6 out of 9 patents)

bronzeMedal Arja Marketta Kalapudas (6 out of 14 patents)

4.  Markku Anttila (4 out of 5 patents)

5.  Maire Eloranta (3 out of 9 patents)

6.  Kaija Halonen (3 out of 6 patents)

7.  Veli-Matti Lehtola (3 out of 4 patents)

8.  Marja Sodervall (3 out of 3 patents)

9.  Mikko Unkila (2 out of 8 patents)

10.  Helena Korte (2 out of 3 patents)

11.  Mervi Hiilovaara-Teijo (2 out of 2 patents)

12.  Patrik Eklund (2 out of 2 patents)

13.  Marja Södervall (2 out of 2 patents)

14.  Lauri V Kangas (2 out of 35 patents)

15.  Jenni Bernoulli (1 out of 2 patents)


22 patents:

1. 10780063 - Method for the treatment or prevention of lower urinary tract symptoms (2020-09-22),
2. 9993442 - Method for the treatment or prevention of lower urinary tract symptoms (2018-06-12),
3. 9855224 - Method for enhancing the bioavailability of ospemifene (2018-01-02),
4. 9566252 - Method for the alleviation of dyspareunia in women (2017-02-14),
5. 9114106 - Method for the treatment or prevention of lower urinary tract symptoms (2015-08-25),
6. 8962693 - Method for the treatment or prevention of lower urinary tract symptoms (2015-02-24),
7. 8772353 - Method for enhancing the bioavalability of ospemifene (2014-07-08),
8. 8758821 - Oral formulations of ospemifene (2014-06-24),
9. 8642079 - Solid formulations of ospemifene (2014-02-04),
10. 8470890 - Method for enhancing the bioavailability of ospemifene (2013-06-25),
11. 8293947 - Method for the preparation of therapeutically valuable triphenylbutene derivatives (2012-10-23),
12. 8236861 - Method for enhancing the bioavailablity of ospemifene (2012-08-07),
13. 7825107 - Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors (2010-11-02),
14. 7812197 - Method for the preparation of therapeutically valuable triphenylbutene derivatives (2010-10-12),
15. 7582677 - Lignan formulations (2009-09-01),
Company Overview
Hormos Medical Corporation is a pioneering entity based in Turku, Finland, specializing in the development of innovative medical technologies. The company focuses on enhancing patient care through advanced solutions in the field of diagnostics and therapeutic devices. With a commitment to research and development, Hormos Medical aims to address critical healthcare challenges, leveraging cutting-edge technology to improve clinical outcomes and streamline medical processes. Its expertise spans various domains within the medical device sector, contributing to the evolution of healthcare practices.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#7 in Turku

#158 in Finland

#28,807 in the World

Turku, FI
Turku, Finland

Hormos Medical Corporation

Forward Citations = 34

34 inventors:

goldMedal Risto Santti (6 out of 12 patents)

silverMedal Tomi Streng (6 out of 9 patents)

bronzeMedal Arja Marketta Kalapudas (6 out of 14 patents)

4.  Markku Anttila (4 out of 5 patents)

5.  Maire Eloranta (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hormos Medical Corporation. Retrieved from https://idiyas.com/company/hormos-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…